Cypress Capital Management (Wyoming)’s AbbVie ABBV Stock Holding History

Cypress Capital Management (Wyoming)’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$36.8K	Hold	169	–	–	0.03%	107
2025 Q4	$38.6K	Hold	169	–	–	0.04%	96
2025 Q3	$39.1K	Hold	169	–	–	0.04%	96
2025 Q2	$31.4K	Hold	169	–	–	0.03%	101
2025 Q1	$35.4K	Buy	+169	New	+$32.9K	0.04%	89
2021 Q3	–	Sell	-200	Closed	-$23K	–	239
2021 Q2	$23K	Hold	200	–	–	0.02%	173
2021 Q1	$22K	Hold	200	–	–	0.02%	166
2020 Q4	$21K	Hold	200	–	–	0.02%	154
2020 Q3	$18K	Hold	200	–	–	0.02%	138
2020 Q2	$20K	Hold	200	–	–	0.02%	130
2020 Q1	$15K	Sell	200 -500	-71%	-$42.6K	0.02%	115
2019 Q4	$62K	Hold	700	–	–	0.06%	103
2019 Q3	$53K	Sell	700 -578	-45%	-$39.6K	0.06%	98
2019 Q2	$93K	Hold	1,278	–	–	0.11%	89
2019 Q1	$103K	Hold	1,278	–	–	0.14%	80
2018 Q4	$118K	Hold	1,278	–	–	0.23%	70
2018 Q3	$121K	Buy	1,278 +400	+46%	+$37.9K	0.12%	111
2018 Q2	$81K	Hold	878	–	–	0.09%	131
2018 Q1	$83K	Buy	878 +228	+35%	+$25K	0.1%	119
2017 Q4	$63K	Sell	650 -650	-50%	-$61.3K	0.07%	142
2017 Q3	$116K	Sell	1,300 -2,035	-61%	-$155K	0.14%	100
2017 Q2	$242K	Hold	3,335	–	–	0.28%	61
2017 Q1	$217K	Hold	3,335	–	–	0.27%	62
2016 Q4	$208K	Buy	3,335 +1,500	+82%	+$91.6K	0.22%	63
2016 Q3	$116K	Hold	1,835	–	–	0.15%	81
2016 Q2	$114K	Hold	1,835	–	–	0.15%	71
2016 Q1	$105K	Hold	1,835	–	–	0.14%	80
2015 Q4	$109K	Hold	1,835	–	–	0.14%	86
2015 Q3	$99.8K	Hold	1,835	–	–	0.13%	85
2015 Q2	$123K	Hold	1,835	–	–	0.14%	90
2015 Q1	$107K	Hold	1,835	–	–	0.13%	92
2014 Q4	$120K	Buy	+1,835	New	+$116K	0.16%	82

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Cypress Capital Management (Wyoming)'s ABBV Position: Q1 2026 in Review

Cypress Capital Management (Wyoming) held its AbbVie (ABBV) position steady in Q1 2026 at 169 shares worth $36.8K. The position accounts for 0.03% of the portfolio, ranked #107.

Cypress Capital Management (Wyoming) first reported a position in ABBV in Q4 2014 and has held it in 32 quarters since. The position peaked at $242K in Q2 2017. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Cypress Capital Management (Wyoming) held 169 shares of AbbVie worth $36.8K as of Q1 2026.
Cypress Capital Management (Wyoming) left its AbbVie share count unchanged in Q1 2026.
AbbVie made up 0.03% of Cypress Capital Management (Wyoming)'s portfolio in Q1 2026, its #107 holding.
Cypress Capital Management (Wyoming) first reported a position in AbbVie in Q4 2014 and has held it in 32 quarters since.
Cypress Capital Management (Wyoming)'s AbbVie position peaked at $242K in Q2 2017.
4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Cypress Capital Management (Wyoming)'s 13F filing for Q1 2026, filed 8 May 2026.